Medicare Enrolled

Dr. Tarcisio Diaz, MD

Endocrinology · Corona, CA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
900 S MAIN ST, Corona, CA 92882
9517389081
In practice since 2007 (19 years)
NPI: 1346379583 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Diaz from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Diaz? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Diaz

Dr. Tarcisio Diaz is an endocrinology specialist in Corona, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Diaz performed 811 Medicare services across 322 unique beneficiaries.

Between the years covered by Open Payments, Dr. Diaz received a total of $12,544 from 51 pharmaceutical and/or device companies across 664 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in endocrinology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Diaz is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 48% volume in CA $12,544 industry payments

Medicare Practice Summary

Medicare Utilization ↗
811
Medicare services
Top 48% in CA for endocrinology
322
Unique beneficiaries
$98
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~43 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
315 $101 $155
Continuous glucose monitoring, sensor under skin
This procedure involves continuous monitoring of blood sugar levels in tissue fluid using a sensor placed under the skin with provider-supplied equipment.
173 $124 $200
Continuous glucose monitoring with interpretation
This procedure involves monitoring blood sugar levels in tissue fluid using a sensor placed under the skin, along with the interpretation and reporting of the results.
172 $28 $75
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
127 $144 $200
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
24 $137 $250
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$12,544
Total received (2018-2024)
Avg $1,792/year across 7 years
Top 18% in CA for endocrinology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
51
Companies
664
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$12,413 (99.0%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$131 (1.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,904
2023
$1,968
2022
$1,835
2021
$1,994
2020
$1,138
2019
$1,391
2018
$2,313

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Amgen Inc.
$285
Xeris Pharmaceuticals, Inc.
$276
Corcept Therapeutics
$232
Insulet Corporation
$174
Abbott Laboratories
$131
CeQur Corporation
$115
RECORDATI_RARE_DISEASES_INC.
$65
Lilly USA, LLC
$55
Medtronic, Inc.
$54
Bayer Healthcare Pharmaceuticals Inc.
$54
Antares Pharma, Inc.
$53
Boehringer Ingelheim Pharmaceuticals, Inc.
$52
Novartis Pharmaceuticals Corporation
$50
Esperion Therapeutics, Inc.
$45
AIMMUNE THERAPEUTICS, INC.
$44
SANOFI-AVENTIS U.S. LLC
$33
Amphastar Pharmaceuticals, Inc.
$31
Dexcom, Inc.
$30
Ascendis Pharma Inc
$27
Tandem Diabetes Care, Inc.
$23
ABBVIE INC.
$21
IBSA Pharma Inc.
$20
Tactile Systems Technology Inc
$18
Acella Pharmaceuticals, LLC
$16
Top 3 companies account for 41.6% of 2024 payments
All-time payments by company (2018-2024) ›
Amgen Inc.
$1,730
Corcept Therapeutics
$1,302
Medtronic MiniMed, Inc.
$925
Abbott Laboratories
$743
Xeris Pharmaceuticals, Inc.
$673
Insulet Corporation
$656
Novo Nordisk Inc
$620
AstraZeneca Pharmaceuticals LP
$507
Dexcom, Inc.
$366
SANOFI-AVENTIS U.S. LLC
$364
Boehringer Ingelheim Pharmaceuticals, Inc.
$347
Nestle HealthCare Nutrition Inc.
$325
Mannkind Corporation
$325
Esperion Therapeutics, Inc.
$279
Smith+Nephew, Inc.
$271
Tandem Diabetes Care, Inc.
$251
Lilly USA, LLC
$238
Novartis Pharmaceuticals Corporation
$202
Bayer HealthCare Pharmaceuticals Inc.
$199
Medtronic, Inc.
$193
MannKind Corporation
$171
Shire North American Group Inc
$161
Janssen Pharmaceuticals, Inc
$153
AbbVie Inc.
$150
CeQur Corporation
$145
Bayer Healthcare Pharmaceuticals Inc.
$131
Merck Sharp & Dohme Corporation
$108
NESTLE HEALTHCARE NUTRITION INC.
$102
Ipsen Biopharmaceuticals, Inc
$90
Horizon Therapeutics plc
$83
RECORDATI_RARE_DISEASES_INC.
$65
Antares Pharma, Inc.
$53
Regeneron Healthcare Solutions, Inc.
$49
AIMMUNE THERAPEUTICS, INC.
$44
ABBVIE INC.
$44
IBSA Pharma Inc.
$44
Amphastar Pharmaceuticals, Inc.
$44
Smith & Nephew, Inc.
$42
Supernus Pharmaceuticals, Inc.
$41
DEXCOM, INC.
$34
Bigfoot Biomedical Inc
$32
Amryt Pharma Holdings Ltd
$32
Acella Pharmaceuticals, LLC
$32
ACELL, INC.
$28
Ascendis Pharma Inc
$27
Ultragenyx Pharmaceutical Inc.
$24
AbbVie, Inc.
$24
Inogen, Inc.
$20
Baxter Healthcare
$19
Tactile Systems Technology Inc
$18
PFIZER INC.
$18
Top 3 companies account for 31.5% of all-time payments
Associated products mentioned in payments ›
AFREZZA · BAQSIMI · BYDUREON · COLLAGENASE SANTYL · CREON · CRYSVITA · CeQur Simplicity · Creon · DEXCOM G6 CGM SYSTEM · DEXCOM G6 TRANSMITTER · Dexcom G6 Transmitter · ENTRESTO · EVENITY · FARXIGA · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · Flexitouch Plus · FreeStyle Libre · FreeStyle Libre 2 · FreeStyle Libre blood glucose Flash Monitoring System · FreeStyle Lite system · GRAFIX PL · GVOKE HYPOPEN · GVOKE PFS · HUMULIN · Hillrom - Life 2000 Ventilation System · INOGEN ONE G5 OXYGEN CONCENTRATOR - BLUETOOTH · INPEN SMART INSULIN DELIVERY SYSTEM · INVOKANA · JANUVIA · JARDIANCE · KEVEYIS · Kerendia · Korlym · LEQVIO · LINZESS · LYRICA · LYUMJEV · Levemir · MINIMED 780G · MYALEPT · MYCAPSSA · Minimed 670G System · Minimed 770G System · NATPARA · NATPARA (PARATHYROID HORMONE) · NEXLETOL · NEXLIZET · NP Thyroid 60 · Omnipod · Ozempic · PRALUENT · Prolia · RECORLEV · Repatha · SIGNIFOR LAR · SOLIQUA 100/33 · SOMATULINE DEPOT · STEGLATRO · SYNTHROID · Santyl · TEPEZZA · TLANDO · TOUJEO · TZIELD · Tirosint · UBRELVY · UNITY DIABETES MANAGEMENT SYSTEM · VERSAJET II · Victoza · XARELTO · XYOSTED · ZENPEP · t-slim insulin pump · t:slim X2 Insulin Pump with Control-IQ · t:slim X2 insulin pump
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (99%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for an endocrinology specialist in Corona?
Compare endocrinologists in the Corona area by procedure volume, costs, and industry payment transparency.
Browse endocrinologists nearby

Geographic Context

Endocrinologists within 10 mi
107
Per 100K population
4.4
County median income
$89,672
Nearest hospital
CORONA REGIONAL MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Diaz is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement in the top 18% of CA peers, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Diaz experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Diaz performed 315 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Diaz receive payments from pharmaceutical companies?
Yes. Dr. Diaz received a total of $12,544 from 51 companies across 664 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Diaz's costs compare to other endocrinologists in Corona?
Dr. Diaz's average Medicare payment per service is $98. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Diaz) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →